Damon Inc (DMN) NPV

Sell:$0.35Buy:$0.38$0.03 (6.98%)

Prices delayed by at least 15 minutes
Sell:$0.35
Buy:$0.38
Change:$0.03 (6.98%)
Prices delayed by at least 15 minutes
Sell:$0.35
Buy:$0.38
Change:$0.03 (6.98%)
Prices delayed by at least 15 minutes

Company Information

About this company

Damon Inc., formerly Grafiti Holding Inc., is a light electric vehicle manufacturer. The Company is focused on electric motorcycles, including proprietary electric powertrain, shifting and predictive awareness technologies. Anchored by HyperDrive electric powertrain, all Damon motorcycles are focused on delivering power and range that exceeds that of gas without noise, emissions, or maintenance hassles. Its safety technologies include CoPilot and Shift. HyperDrive is a patented, 500V exoskeleton drive train system. It combines the battery, BMS, charger, and inverter into a single water-tight enclosure that not only serves as the motorcycle chassis but also ensures reduced weight, enhanced balance, and almost zero maintenance. Its motorcycles include HyperSport and Hyperfighter. The Damon HyperSport is an aerodynamic motorcycle.

Key people

Dominique Kwong
Interim Chief Executive Officer, Director
Baljinder Bhullar
Chief Financial Officer, Director
Derek Dorresteyn
Chief Technology Officer
Amber Spencer
Chief Marketing Officer
Shashi Tripathi
Non-Executive Independent Chairman of the Board
Melanie Figueroa
Director
Karan Sodhi
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United Kingdom
  • Sector
    Consumer Cyclical
  • Industry
    Recreational Products
  • ISIN
    CA2357501063
  • Market cap
    $9.92m
  • Employees
    2
  • Shares in issue
    22.03m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.